CervoMed (CRVO) Non Operating Income (2009 - 2026)
CervoMed (CRVO) posted Non Operating Income of $106,895 for Q2 2026, down 70.1% from $357,871 a year earlier and down 27.0% from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) Non Operating Income (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at CervoMed was $815,050, down 58.1% year-over-year; for FY2025, it was $1.33 million, down 31.4% from FY2024.
- In prior years, CervoMed's Non Operating Income was $1.94 million in FY2024 (-65.7%), $5.64 million in FY2023 and -$2.33 million in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Non Operating Income since Q1 2024.
- On a year-over-year basis, Non Operating Income has declined in each of the last five quarters, with growth averaging 48.4% over the last eight quarters.
- The strongest year-over-year quarter for Non Operating Income in the past five years was Q1 2025, with growth of 407.2%; the weakest was Q1 2024, with a decline of 91.0%.
- According to Business Quant data, Non Operating Income for the three prior quarters was $146,366 (Q1 2026), $244,229 (Q4 2025) and $317,560 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | CervoMed | 20.73 Mn | -57.60 Mn | - | 209,519.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 209,519.00 |
| Jun 30, 2026 | 106,895.00 |
| Mar 31, 2026 | 146,366.00 |
| Dec 31, 2025 | 244,229.00 |
| Sep 30, 2025 | 317,560.00 |
| Jun 30, 2025 | 357,871.00 |
| Mar 31, 2025 | 408,850.00 |
| Dec 31, 2024 | 534,907.00 |
| Sep 30, 2024 | 642,732.00 |
| Jun 30, 2024 | 678,194.00 |
| Mar 31, 2024 | 80,603.00 |
| Dec 31, 2023 | 118,052.00 |
| Sep 30, 2023 | 4.83 Mn |
| Jun 30, 2023 | -194,504.00 |
| Mar 31, 2023 | 891,983.00 |
| Dec 31, 2022 | -588,577.00 |
| Sep 30, 2022 | 21,431.00 |
| Dec 31, 2015 | 1,039.00 |
| Sep 30, 2015 | 1,165.00 |
| Jun 30, 2015 | 1,633.00 |
API Access
CervoMed Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();